Trials / Sponsors / Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
Industry · 6 registered clinical trials — 5 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study to Evaluate the Efficacy and Safety of IBI310 and Sintilimab Combination Therapy in Patients With Hepa Hepatocellular Carcinoma (HCC) | Phase 2 / Phase 3 | 2026-03-27 |
| Recruiting | IBI354 With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast HER2-positive Breast Cancer | Phase 3 | 2026-02-10 |
| Recruiting | A Study of Picankibart in Patients With Active Psoriatic Arthritis Psoriatic Arthritis | Phase 2 / Phase 3 | 2025-12-18 |
| Recruiting | A Study to Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque Ps Psoriasis | Phase 3 | 2025-12-03 |
| Active Not Recruiting | A Study of Switching to Picankibart in Chinese Patients With Plaque Psoriasis With an Inadequate Response to I Plaque Psoriasis | Phase 3 | 2025-05-27 |
| Recruiting | Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors Solid Tumors | Phase 1 | 2025-04-29 |